Elevation Oncology, Inc.

NASDAQ:ELEV

0.5108 (USD) • At close March 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -44.485-45.704-95.08-32.039-17.265-5.882
Depreciation & Amortization 0.0240.0390.0270.0180.0150
Deferred Income Tax 000-1.6375.1370
Stock Based Compensation 4.283.3353.2061.5710.0520.014
Change In Working Capital 3.839-13.696.290.2834.90.423
Accounts Receivables 000000
Inventory 000000
Accounts Payables 0.052-5.8550.711-0.035.2190.46
Other Working Capital 3.787-7.8355.5790.313-0.319-0.037
Other Non Cash Items -0.022-0.160.0741.637-5.137-0.451
Operating Cash Flow -36.364-56.18-85.483-30.167-12.298-5.45
Investing Activities:
Investments In Property Plant And Equipment 00-0.0860-0.0710
Acquisitions Net 000.044000
Purchases Of Investments -69.565-42.657-112.312000
Sales Maturities Of Investments 61.254.268000
Other Investing Activites 00-0.044000
Investing Cash Flow -8.36511.543-44.3980-0.0710
Financing Activities:
Debt Repayment 0030000
Common Stock Issued 44.20746.503097.0620.027.19
Common Stock Repurchased -0.048-0.024-0.035000
Dividends Paid 000000
Other Financing Activities 0.7791.496-0.451-0.01190.00910.785
Financing Cash Flow 44.93847.97529.51497.05190.0297.19
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 0.2093.338-100.36766.88477.661.74
Cash At End Of Period 49.46449.25545.917146.28479.41.74